Related Stories
Progress
For Sopharma AD this effort is another contribution to an excellent corporate governance file.
| Financial structure | |||
|---|---|---|---|
| BGN '000 | 31.12.2022 | 31.12.2021 | 31.12.2020 |
| Total debt capital | 283,295 | 330,622 | 425,329 |
| Loans from banks | 195,872 | 269,766 | 321,020 |
| Leasing and factoring obligations | 87,423 | 60,856 | 104,309 |
| Cash and cash equivalents | 19,635 | 37,717 | 25,293 |
| Net debt | 268,979 | 292,905 | 400,190 |
| Equity attributable to equity holders of the parent | 704,658 | 646,975 | 553,269 |
| Non-controlling interest | 11,976 | 11,893 | 13,326 |
| Total equity | 716,634 | 658,868 | 566,595 |
| Net debt/Total equity | 38% | 44% | 71% |
| Net debt/EBITDA | 1,92 | 2,51 | 4,33 |